Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 273.67M P/E - EPS this Y -42.30% Ern Qtrly Grth -
Income -32.74M Forward P/E -2.79 EPS next Y -32.40% 50D Avg Chg 27.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -14.00%
Dividend N/A Price/Book 0.95 EPS next 5Y - 52W High Chg -72.00%
Recommedations 2.00 Quick Ratio 40.20 Shares Outstanding 41.10M 52W Low Chg 81.00%
Insider Own 9.92% ROA -10.56% Shares Float 2.58M Beta 2.92
Inst Own 104.00% ROE -12.25% Shares Shorted/Prior 1.88M/1.78M Price 6.78
Gross Margin - Profit Margin - Avg. Volume 114,546 Target Price 19.00
Oper. Margin - Earnings Date - Volume 69,363 Change -1.02%
About Third Harmonic Bio, Inc.

Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. The company develops oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It is also developing THB335, an oral small molecule KIT inhibitor for the treatment of mast cell-mediated skin, respiratory, and gastrointestinal conditions. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in San Francisco, California.

Third Harmonic Bio, Inc. News
11/11/24 Wall Street Analysts Believe Third Harmonic Bio, Inc. (THRD) Could Rally 26.67%: Here's is How to Trade
11/07/24 Third Harmonic Bio to Participate in Upcoming Investor Conferences in November
11/07/24 Third Harmonic Bio Announces Third Quarter 2024 Financial Results
09/16/24 Third Harmonic Bio (NASDAQ:THRD) Is In A Strong Position To Grow Its Business
09/10/24 Third Harmonic Bio to Participate in Upcoming Investor Conferences in September
08/26/24 Third Harmonic Bio to Participate in Upcoming Investor Conferences
08/08/24 Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
05/28/24 Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference
05/15/24 Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
05/14/24 AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
05/10/24 Insider Sale: CEO Natalie Holles Sells Shares of Third Harmonic Bio Inc (THRD)
04/15/24 Third Harmonic Bio Inc CEO Natalie Holles Sells 13,558 Shares
04/08/24 We're Not Worried About Third Harmonic Bio's (NASDAQ:THRD) Cash Burn
03/28/24 Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
03/26/24 Third Harmonic Bio Inc (THRD) Reports Decreased Net Loss in Q4, Aligns with Analyst Projections
03/26/24 Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
02/26/24 Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
01/04/24 Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update
12/29/23 Are You Looking for a Top Momentum Pick? Why Third Harmonic Bio, Inc. (THRD) is a Great Choice
12/08/23 Insider Sell Alert: Third Harmonic Bio Inc's Julie Person Divests 12,863 Shares
THRD Chatroom

User Image JudithKaur Posted - 1 day ago

$THRD $ARCT $EBS LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

User Image PenkeTrading Posted - 5 days ago

I found you a MACD Bullish Reversal Divergence on the daily chart of Third Harmonic Bio Inc.. $THRD #BullishReversalDivergence #NASDAQ

User Image LaurynRamos Posted - 6 days ago

$THRD $ARCT MYNZ Wow, this is insane news! Don't miss out. The train is leaving the station. Add it to your watchlist to see what happens next. 😏

User Image Doozio Posted - 1 week ago

$xbi is NOW in RYTM with $iwm from a new 🧠 $dawn 🧠👀 to da FUTUre of 🧠⏰ n $thrd INTA 🧠⏰♾️

User Image Doozio Posted - 2 weeks ago

On the $thrd day of the week it appears an obvious MNDY 🐑 INTA 🧠⏰♾️

User Image Doozio Posted - 2 weeks ago

faaatch 💣 or let’s do moar then a $thrd of some DRUGs during 🧠⏰♾️

User Image Doozio Posted - 2 weeks ago

list of $xbi stonks ready to get $spry ? it’s moar then a $thrd of them which is much moar then $elvn during 🧠⏰♾️

User Image insiderbuyingselling Posted - 10/31/24

$THRD new insider selling: 1000000 shares. http://insiderbuyingselling.com/?t=THRD

User Image insiderbuyingselling Posted - 10/31/24

$THRD new insider selling: 2673 shares. http://insiderbuyingselling.com/?t=THRD

User Image _www_larval_com_ Posted - 10/29/24

$THRD just reverted 3% higher to -5% (~1Mv) in the last few minutes, 11/15 options, follow for more volatility.

User Image Doozio Posted - 1 month ago

$SUPN SMMTing MAMA don’t lie during 🧠⏰ NOW go $thrd NEXN during 🧠⏰♾️

User Image Doozio Posted - 1 month ago

$SUPN SMMTin always listen to MAMA as SMMT special has already begun in da FUTUre of 🧠⏰ which comes in $thrd s NOW during 🧠⏰♾️

User Image Doozio Posted - 1 month ago

$ELVN $THRD whut ⏰

User Image Doozio Posted - 09/30/24

$thrd x $elvn = 🧠⏰♾️

User Image Doozio Posted - 09/30/24

$THRD MAMA said da FUTUre of 🧠⏰ is NOW during 🧠⏰♾️

User Image PenkeTrading Posted - 2 months ago

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Third Harmonic Bio Inc.. Is that bullish or bearish? $THRD #RsiOverbought #NASDAQ

User Image insiderbuyingselling Posted - 2 months ago

$THRD new insider selling: 10000 shares. http://insiderbuyingselling.com/?t=THRD

User Image Doozio Posted - 2 months ago

Da fook MAMA say wen da $thrd time is during 🧠⏰♾️?

User Image G101SPM Posted - 2 months ago

#SHOWTIME ^^ TD Cowen Chronic Urticaria Summit (September 20) Scheduled to appear: $BPMC, $CLDX, $JSPR, $THRD

User Image Doozio Posted - 2 months ago

MAMA said $thrd times a charm in 🧠⏰

User Image Doozio Posted - 2 months ago

$THRD chop chop …….

User Image Stocksrunner Posted - 3 months ago

Friday Gainers Alert! 🚀🎉 Check out these stocks that are on fire: $QNTM $ITI $MGOL $THRD $DOCS! Keep an eye on them for potential moves today—let’s ride this wave! 📈💥 https://stocksrunner.com/trending

User Image Stock_Titan Posted - 3 months ago

$THRD Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update https://www.stocktitan.net/news/THRD/third-harmonic-bio-announces-second-quarter-2024-financial-results-9lojcdhbksba.html

User Image NVDAMillionaire Posted - 3 months ago

$THRD Third Harmonic Bio, Inc. (THRD): A Promising Biotech Tackling Mast Cell-Mediated Diseases http://beyondspx.com/2024/08/02/third-harmonic-bio-inc-thrd-a-promising-biotech-tackling-mast-cell-mediated-diseases/

User Image StockInvest_us Posted - 07/23/24

Signal alert: $THRD - Possible Runner https://stockinvest.us/l/gHzQ2A22PN

User Image DesiMiami Posted - 4 months ago

$THRD same thing here 👀 moved in silence trying to break that 12.69 …

User Image DesiMiami Posted - 4 months ago

$THRD anyone can share what’s the catalyst here ? I noticed Stifel price target $23 . Can’t find any info on why . Honest answers appreciated

User Image insiderbuyingselling Posted - 06/29/24

$THRD new insider selling: 10000 shares. http://insiderbuyingselling.com/?t=THRD

User Image erevnon Posted - 5 months ago

Stifel initiates coverage on Third Harmonic Bio $THRD at Buy rating and a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image DonCorleone77 Posted - 5 months ago

$THRD $CLDX Third Harmonic Bio initiated with a Buy at Stifel Stifel initiated coverage of Third Harmonic Bio (THRD) with a Buy rating and $23 price target. Mast cells represent a largely untapped pathogenic target for inflammatory conditions, and Third Harmonic Bio is the only oral wild-type KIT inhibitor pure play, with potential "first-in-class positioning", the analyst tells investors in a research note. The inhibition of KIT is a highly-validated approach to treating mast cell driven diseases given the validation not only from Celldex's (CLDX) Barzolvolimab, but also from Third Harmonic first-gen small molecule KIT inhibitor THB001, which demonstrated a clear efficacy signal prior to discontinuation of the program due to liver toxicity, the firm added.

Analyst Ratings
Morgan Stanley Overweight Aug 9, 24
Stifel Buy Jun 18, 24
Raymond James Outperform Jun 7, 24
Morgan Stanley Equal-Weight Aug 11, 23
Morgan Stanley Equal-Weight Dec 16, 22
Jefferies Hold Dec 16, 22
Jefferies Buy Oct 10, 22
Morgan Stanley Overweight Oct 10, 22
Cowen & Co. Outperform Oct 10, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
BVF PARTNERS L P/IL 10% Owner 10% Owner Dec 20 Buy 4.11 214,063 879,799 241,309 12/22/22
ORBIMED ADVISORS LLC Director Director Sep 19 Buy 17 300,000 5,100,000 5,779,071 09/21/22
Bonita David P Director Director Sep 19 Buy 17 300,000 5,100,000 5,779,071 09/21/22
Atlas Venture Fund XI, L.P. 10% Owner 10% Owner Sep 19 Buy 17 300,000 5,100,000 10,313,763 09/19/22